Mycophenolate mofetil suspension in pediatric renal transplantation: Three-year data from the tricontinental trial

Pediatric Transplantation

Volumn 9, Issue 4, 2005, Pages 504-511

  Höcker, Britta ^a   Weber, Lutz T ^a   Bunchman, Timothy ^b   Rashford, Michelle ^c   Tönshoff, Burkhard ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b HELEN DEVOS CHILDREN S HOSPITAL   (United States)

^c ROCHE PRODUCTS LTD   (United Kingdom)

Author keywords

Immunosuppression; Induction therapy; Mycophenolate mofetil; Pediatric renal transplantation

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; DACLIZUMAB; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; THYMOCYTE ANTIBODY;

ABDOMINAL PAIN; ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGE; ANEMIA; ARTICLE; ASPERGILLUS; CANDIDA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CRYPTOCOCCUS; CYTOMEGALOVIRUS; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; GRAFT SURVIVAL; HERPES SIMPLEX VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; LISTERIA MONOCYTOGENES; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MICROEMULSION; MULTICENTER STUDY; OLIGURIA; OPPORTUNISTIC INFECTION; PEDIATRIC SURGERY; PNEUMOCYSTIS JIROVECI; PROSPECTIVE STUDY; SEPSIS; SURVIVAL RATE; SUSPENSION; VARICELLA ZOSTER VIRUS;

ADOLESCENT; ADRENAL CORTEX HORMONES; ANALYSIS OF VARIANCE; ANTILYMPHOCYTE SERUM; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DRUG THERAPY, COMBINATION; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; KIDNEY TRANSPLANTATION; MYCOPHENOLIC ACID; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SUSPENSIONS; TREATMENT OUTCOME;

EID: 23844482799     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2005.00335.x     Document Type: Article

References (16)

1. ELSHIHABI I, CHAVERS B, DONALDSON L, EMMETT L, TEJANI A. Continuing improvement in cadaver donor graft survival in North American children: the 1998 annual report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 2000: 4: 235-246.
2. TEJANI A, CORTES L, STABLEIN D. Clinical correlates of chronic rejection in pediatric renal transplantation. A report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 1996: 61: 1054-1058.
3. JOHNSON RWG, WEBB NJA, LEWIS MA, POSTLEWAITH RJ, DYER PA, CONNOLY JK. Outcome of pediatric cadaveric renal transplantation: 10 year study. Kidney Int 1996: 49: S72-S76.
4. HIRATA M, TERASAKI PI. Pediatric renal transplantation. In: CECKA JM, TERASAKI PI, eds. Clinical Transplants. Los Angeles, CA: UCLA Tissue Typing Laboratory, 2000: pp. 1-18.
5. STASKEWITZ A, KIRSTE G, TÖNSHOFF B, WEBER LT, BOSWALD M, BURGHARD R, HELMCHEN U, BRANDIS M, ZIMMERHACKL LB. Mycophenolate mofetil in pediatric renal transplantation without induction therapy: results after 12 months of treatment. Transplantation 2001: 71: 638-644.
6. JUNGRAITHMAYR T, STASKEWITZ A, KIRSTE G, BOSWALD M, BULLA M, BURGHARD R, DIPPELL J, GREINER C, HELMCHEN U, KLARE B, KLAUS G, LEICHTER HE, MIHATSCH M, MICHALK DV, MISSELWITZ J, PLANK C, QUERFELD U, WEBER LT, WIESEL M, TÖNSHOFF B, ZIMMERHACKL LB. Pediatric transplantation with mycophenolate mofetil-based immunosuppression without induction: results after three years. Transplantation 2003: 75: 454-461.
7. BUNCHMAN T, NAVARRO M, BROYER M, SHERBOTIE J, CHAVERS B, TÖNSHOFF B, BIRK P, LERNER G, LIRENMAN D, GREENBAUM L, WALKER R, ZIMMERHACKL LB, BLOWEY D, CLARK G, ETTENGER R, ARTERBURN S, KLAMERUS K, FONG A, TANG H, THOMAS S, RAMOS E. The use of mycophenolate mofetil suspension in pediatric renal allograft recipients. Pediatr Nephrol 2001: 16: 978-984.
8. WEBER LT, SHIPKOVA M, LAMERSDORF T, NIEDMANN PD, WIESEL M, MANDELBAUM A, ZIMMERHACKL LB, SCHUTZ E, MEHLS O, OELLERICH M, ARMSTRONG VW, TÖNSHOFF B. Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients. German Study group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients. J Am Soc Nephrol 1998: 9: 1511-1520.
9. BALTZAN M, GEORGE D. Renal allograft pathology: the Banff classification. Kidney Int 1999: 56: 1602-1603.
10. SHULL BC, HAUGHEY D, KOUP JR, BALIAH T, LI PK. A useful method for predicting creatinine clearance in children. Clin Chem 1978: 24: 1167-1169.
11. US RENAL TRANSPLANT MYCOPHENOLATE MOFETIL STUDY GROUP. Mycophenolate mofetil in cadaveric renal transplantation. Am J Kidney Dis 1999: 34: 296-303.
12. MATHEW TH. A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation 1998: 65: 1450-1454.
13. European Mycophenolate Mofetil Cooperative Study Group. Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. Transplantation 1999: 68: 391-396.
14. VIRJI M, CARTER JE, LIRENMAN DS. Single-center experience with mycophenolate mofetil in pediatric renal transplant recipients. Pediatr Transplant 2001: 5: 293-296.
15. NEU AM, Ho PL, FINE RN, FURTH SL, FIVUSH BA. Tacrolimus vs. cyclosporine A as primary immunosuppression in pediatric renal transplantation: a NAPRTCS study. Pediatr Transplant 2003: 7: 217-222.
16. WEBER LT, SHIPKOVA M, ARMSTRONG VW, WAGNER N, SCHUTZ E, MEHLS O, ZIMMERHACKL LB, OELLERICH M, TÖNSHOFF B. The pharmacokinetic- pharmacodynamic relationship for total and free mycophenolic acid in pediatric renal transplant recipients: a report of the German study group on mycophenolate mofetil therapy. J Am Soc Nephrol 2002: 13: 759-768.